DFTX Definium Therapeutics, Inc.

HealthcareBiotechnology
$23.20
▼ 0.94%
34
QScore Signal
Short
Confidence: MEDIUM
Long-Term
25
Short-Term
42

Value

29
P/E-10.63
8
P/B9.05
42
P/S0.00
70
EV/EBITDA-10.99
5

Growth

35
Revenue Growth0.0%
28
EPS Growth-33.8%
41
FCF Growth-66.3%
37

Momentum

75
12-Month Return267.7%
100
3-Month Return42.8%
100
1-Month Return10.4%
72
RSI (14)52.90
56
50/200 MABearish
30

Profitability

16
ROE-102.5%
31
ROA-59.2%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-5.2%
0

Risk

9
Beta2.38
20
60-Day Volatility51.2%
0

Generated 5/7/2026, 10:45:02 PM · How is this calculated?

QScore Analysis